Literature DB >> 24282367

Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer.

Zhen-Jun Li1, Xiao-Jiang Ying, Hong-Liang Chen, Ping-Jiang Ye, Zhi-Liang Chen, Gang Li, Hua-Feng Jiang, Jiang Liu, Shu-Zhen Zhou.   

Abstract

AIM: To investigate the expression of insulin-like growth factor-1 (IGF-1)/insulin-like growth factor-1 receptor (IGF-1R) in colorectal cancer (CRC) tissues and to analyze their correlation with lymphangiogenesis and lymphatic metastasis.
METHODS: Immunohistochemistry was used to evaluate IGF-1 and IGF-1R expression and lymphatic vessel density (LVD) in 40 CRC specimens. The correlation between IGF-1/IGF-1R and LVD was investigated. Effects of IGF-1 on migration and invasion of CRC cells were examined using transwell chamber assays. A LoVo cell xenograft model was established to further detect the role of IGF-1 in CRC lymphangiogenesis in vivo.
RESULTS: Elevated IGF-1 and IGF-1R expression in CRC tissues was correlated with lymph node metastasis (r = 0.715 and 0.569, respectively, P < 0.05) and tumor TNM stage (r = 0.731 and 0.609, P < 0.05). A higher LVD was also found in CRC tissues and was correlated with lymphatic metastasis (r = 0.405, P < 0.05). A positive correlation was found between LVD and IGF-1R expression (r = 0.437, P < 0.05). Transwell assays revealed that IGF-1 increased the migration and invasion of CRC cells. In vivo mouse studies showed that IGF-1 also increased LVD in LoVo cell xenografts.
CONCLUSION: IGF-1/IGF-1R signaling induces tumor-associated lymphangiogenesis and contributes to lymphatic metastasis of CRC.

Entities:  

Keywords:  Colorectal cancer; Insulin-like growth factor-1; Insulin-like growth factor-1 receptor; Lymphangiogenesis; Lymphatic metastasis

Mesh:

Substances:

Year:  2013        PMID: 24282367      PMCID: PMC3837280          DOI: 10.3748/wjg.v19.i43.7788

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

Review 1.  The IGF-1 receptor in cancer biology.

Authors:  Renato Baserga; Francesca Peruzzi; Krysztof Reiss
Journal:  Int J Cancer       Date:  2003-12-20       Impact factor: 7.396

2.  Prognostic and survival analysis of 837 Chinese colorectal cancer patients.

Authors:  Ying Yuan; Mo-Dan Li; Han-Guang Hu; Cai-Xia Dong; Jia-Qi Chen; Xiao-Fen Li; Jing-Jing Li; Hong Shen
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

3.  Expression of insulin-like growth factor-1 receptor in human colorectal cancer.

Authors:  A Hakam; T J Yeatman; L Lu; L Mora; G Marcet; S V Nicosia; R C Karl; D Coppola
Journal:  Hum Pathol       Date:  1999-10       Impact factor: 3.466

Review 4.  Lymphangiogenesis: a new player in cancer progression.

Authors:  Masayuki Nagahashi; Subramaniam Ramachandran; Omar M Rashid; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

Review 5.  Targeting IGF-1 signaling pathways in gynecologic malignancies.

Authors:  Ilan Bruchim; Haim Werner
Journal:  Expert Opin Ther Targets       Date:  2013-01-07       Impact factor: 6.902

6.  Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.

Authors:  Alexander Hermani; Ashish Shukla; Senad Medunjanin; Haim Werner; Doris Mayer
Journal:  Cell Signal       Date:  2013-03-14       Impact factor: 4.315

7.  Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.

Authors:  Marian L Neuhouser; Elizabeth A Platz; Cathee Till; Catherine M Tangen; Phyllis J Goodman; Alan Kristal; Howard L Parnes; Yuzhen Tao; William D Figg; M Scott Lucia; Ashraful Hoque; Ann W Hsing; Ian M Thompson; Michael Pollak
Journal:  Cancer Prev Res (Phila)       Date:  2013-01-11

8.  Vascular proliferation is important for clinical progress of endometrial cancer.

Authors:  Ingunn M Stefansson; Helga B Salvesen; Lars A Akslen
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

9.  Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer.

Authors:  J Gao; A Knutsen; G Arbman; J Carstensen; B Frånlund; X F Sun
Journal:  Dig Liver Dis       Date:  2008-11-26       Impact factor: 4.088

Review 10.  Insulin-like growth factors and cancer.

Authors:  Gregor Fürstenberger; Hans-Jörg Senn
Journal:  Lancet Oncol       Date:  2002-05       Impact factor: 41.316

View more
  18 in total

Review 1.  Diabetes, Obesity, and Breast Cancer.

Authors:  Chifei Kang; Derek LeRoith; Emily J Gallagher
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

2.  Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.

Authors:  Ga Bin Park; Daejin Kim
Journal:  Mol Cell Biochem       Date:  2017-08-17       Impact factor: 3.396

3.  Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis.

Authors:  Yuanqi Liu; Wei Ren; Yang Bai; Lihong Wan; Xiaodong Sun; Yin Liu; Wenbi Xiong; Yuan-Yuan Zhang; Liming Zhou
Journal:  J Nat Med       Date:  2018-01-19       Impact factor: 2.343

Review 4.  The lymphatic vasculature: An active and dynamic player in cancer progression.

Authors:  Sara Rezzola; Elena C Sigmund; Cornelia Halin; Roberto Ronca
Journal:  Med Res Rev       Date:  2021-09-05       Impact factor: 12.388

5.  Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer.

Authors:  Dingli Song; Dai Zhang; Sisi Chen; Jie Wu; Qian Hao; Lili Zhao; Hong Ren; Ning Du
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

6.  MiR-143 and MiR-145 regulate IGF1R to suppress cell proliferation in colorectal cancer.

Authors:  Jiaojiao Su; Hongwei Liang; Weiyan Yao; Nan Wang; Suyang Zhang; Xin Yan; Hui Feng; Wenjing Pang; Yanbo Wang; Xueliang Wang; Zhen Fu; Yanqing Liu; Chihao Zhao; Junfeng Zhang; Chen-Yu Zhang; Ke Zen; Xi Chen; Yalei Wang
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

7.  EphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal.

Authors:  Xuefeng Jing; Takashi Sonoki; Masayasu Miyajima; Takahiro Sawada; Nanako Terada; Shigeki Takemura; Kazushige Sakaguchi
Journal:  Cancer Med       Date:  2016-02-29       Impact factor: 4.452

8.  LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1.

Authors:  Yang Bai; Chenchen Ren; Baojin Wang; Jingge Xue; Feiyan Li; Jiaxi Liu; Li Yang
Journal:  Cancer Gene Ther       Date:  2021-05-25       Impact factor: 5.987

9.  Inhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma Cells.

Authors:  Tamami Ukaji; Yinzhi Lin; Kouji Banno; Shoshiro Okada; Kazuo Umezawa
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

10.  MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1.

Authors:  Xinyu Tan; Shicai Fan; Wen Wu; Yin Zhang
Journal:  Bone Res       Date:  2015-12-22       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.